Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold... see more

CSE:SONA - Post Discussion

Sona Nanotech Inc > this is great news
View:
Post by newbieontario64 on Jan 17, 2021 8:35pm

this is great news

https://montreal.ctvnews.ca/a-new-mcgill-study-has-found-the-saliva-test-is-as-efficient-in-detecting-covid-19-as-the-nasal-one-1.5268248
Comment by Pandora on Jan 17, 2021 8:47pm
But will it make any difference here with Health Canada calling the shot? https://www.ctvnews.ca/health/coronavirus/rapid-testing-in-canada-lagging-behind-as-u-s-embraces-the-technology-1.5267766
Comment by MikeyH on Jan 18, 2021 5:13am
Well, it's not really great news for SONA though is it? In fact given they failed to achieved HC approval for their swab test, and they have simply mentioned the possibility of a saliva test, I'd say this story is pretty much irrelevant to SONA.
Comment by yongewk on Jan 18, 2021 8:24am
Hey, Mikey, stupid little frog! You come out showing your little frog mind again!!
Comment by MikeyH on Jan 18, 2021 8:45am
Good morning Yong! Nice input there, have you got anything useful to share?
Comment by yongewk on Jan 18, 2021 9:38am
Good morning, Mikey. Have you found any info useful about Sona? Please don't just say bad bad about the company, if you don't have any info back up your idea.
Comment by MikeyH on Jan 18, 2021 9:49am
I'm allowed to respond to posts here, just like you are Yong. So when I saw Dart's excitable post about the one-man band distributors and the saliva testing story (which had nothing whatsoever to do with SONA) I felt a comment to provide a bit of balance was appropriate. Hopefully Dart will be back to prove me wrong, and make me realize that these guys will sell millions of unvalidated ...more  
Comment by yongewk on Jan 18, 2021 10:03am
Hey, Mikey. It s the only time I agree with you about you and me are same, allowed to post here. But only this point. But how can you make that sure Sona cannot achieve the Saliva testing approval!!?? I say Sona management is very good team, they will get approval.
Comment by MikeyH on Jan 18, 2021 10:12am
I am 100% certain they will never get a saliva test to market. Having worked in this sector for many years, I know first hand that saliva is a notoriously difficult sample to develop into a LFA format. It's highly unlikely they will be able to reach adequate levels of sensitivity. And obviously their track record is poor - they have failed to get regulatory approval for their nasal swab test.  ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities